Sign in to view content

Interim Results and Key Learnings from an Ongoing Phase 2 Study of Encapsulated Cell Therapy Compared to Aflibercept in Patients With Wet AMD

Szilárd Kiss, MD

Video
Published 2016

Related

Treatment Response to Antioxidant Supplementation Based on CFH and ARMS2Â Genetic Risk Allele Number in AREDS Patients With No AMD at Baseline
Carl C. Awh, MD, FASRS
Annual Meeting Talks
2016
The OASIS Trial: Efficacy and Safety Outcomes in Subjects With Full-Thickness Macular Hole
Michael Tolentino, MD
Annual Meeting Talks
2016
Gene Expression Modifications in Anti-VEGF Treated Retinal Müller Cells
Baruch D. Kuppermann, MD, PhD
Annual Meeting Talks
2016

Category: AMD-Neovascular

See more